Early HER2+ early breast cancer: APHINITY follow-up confirms DFS benefit of add-on pertuzumabMarch 10, 2021Breast Cancer
HER2+ metastatic breast cancer: Pyrotinib+capecitabine boosts PFS in PHOEBEMarch 10, 2021Breast Cancer
Oncology PracticeAnthracycline-free neoadjuvant regimen safe, effective for TNBCMarch 8, 2021Breast Cancer
Oncology PracticeBreast cancer mortality in under 40s resparks screening debateMarch 5, 2021Breast CancerPreventive Care
Oncology PracticeGenetic testing for breast and ovarian cancer: What has changed and what still needs to change?March 5, 2021Breast CancerGynecologic CancerPatient & Survivor Care
Oncology PracticeArmpit swelling after COVID-19 vaccine may mimic breast cancerMarch 2, 2021Breast CancerCOVID-19 UpdatesPreventive Care
Latest Treatment Options in HR+/HER2- Advanced Breast Cancer in Postmenopausal WomenMarch 1, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticePET predicts response to endocrine therapy in ER+ breast cancerFebruary 19, 2021Breast CancerMetastatic Breast Cancer
Oncology PracticeBreast cancer surgeries deemed ‘low value’ continue, increaseFebruary 18, 2021Breast Cancer
Oncology PracticeHow has the pandemic affected rural and urban cancer patients?February 18, 2021Patient & Survivor CareBreast CancerCNS/Brain CancerCOVID-19 UpdatesGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Oncology PracticeUSPSTF plan for revising breast screening guidance questionedFebruary 12, 2021Breast Cancer
Oncology PracticeNew approach to breast screening based on breast density at 40February 10, 2021Breast CancerPatient & Survivor Care
Oncology PracticeCXR-Net: An AI-based diagnostic tool for COVID-19February 9, 2021Patient & Survivor CareCOVID-19 UpdatesGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLung Cancer
